Sahm ScreenerSaudi Stock Screenerفلتر الأسهم السعودية
Home / Dallah Healthcare Co. / 2025 Annual Results

Dallah Healthcare Co. 2025 Annual Results

Revenue
SAR 4.07B
Net Profit
SAR 541M
EPS
SAR 5.32
Operating Cash Flow
SAR 555M

Dallah Healthcare Co. (4004) reported full year 2025 revenue of SAR 4.07B, up 26.9% from SAR 3.21B in 2024. Net profit came in at SAR 541M, up 11.4% year on year. Earnings per share were SAR 5.32. The company generated SAR 555M in operating cash flow. All figures sourced from CMA-mandated XBRL filings on the Saudi Exchange, processed by Sahm Screener.

Earnings Quality

Of every SAR 1.00 in reported net profit, SAR 1.03 arrived as operating cash flow — indicating Exceptional quality earnings with a cash conversion ratio of 1.03.

Key Financial Metrics

Metric20252024
RevenueSAR 4.07BSAR 3.21B
Net ProfitSAR 541MSAR 485M
Net Margin13.3%15.1%
ROE13.2%14.0%
EPSSAR 5.32SAR 4.83
Total AssetsSAR 9.14BSAR 6.61B
Total EquitySAR 4.08BSAR 3.47B
Total LiabilitiesSAR 5.02BSAR 2.87B
Operating Cash FlowSAR 555MSAR 678M

Year on Year Comparison

Revenue increased by 26.9% compared to 2024. Net profit increased by 11.4%. Both revenue and profit grew — indicating expanding business.

View full company profile →
View all years:
2025202420232022202120202019

Financial data sourced from CMA-mandated XBRL filings published on the Saudi Exchange (Tadawul). Data processed and structured by Sahm Screener (sahmscreener.com). Updated nightly. Last updated: 2026-06-21.